Contractor
GLYPHIC BIOTECHNOLOGIES, INC.
NEW YORK, NY
- UEI
- F57WT7JZDH19
- Resolved by
- uei
- Confidence
- 1.000
Obligated to date
$249,9931
Awards
1
Agencies served
1
One recorded action, Apr 8, 2024.
Sign in to watchRecent awards
| Award | Agency | Place | First action | Current value |
|---|---|---|---|---|
| HT942524P0042 MEDICAL R AND D PURCHASE ORDER FOR A DHA STTR PHASE I, PROPOSAL NO. H23C-001-0042, TITLED, "DEVELOPMENT OF ANTI-GLYCAN ANTIBODIES AGAINST MULTI-DRUG RESISTANT ESKAPE WOUND PATHOGENS" | Department of Defense | NY | Apr 8, 2024 | $249,993 |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
Totals sum obligations across every award attributed to this contractor. Obligations are cumulative funding actions, not the value of work delivered.
- 1Awards are attributed by Unique Entity Identifier F57WT7JZDH19, the government's own recipient identifier, not by name matching.
- 2Award records from USAspending.gov, last refreshed Sep 12, 2026.